STOCK TITAN

UXIN Form 4 Filings

UXIN NASDAQ

Here are the Form 4 insider transactions from Uxin Limited (UXIN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow UXIN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UXIN filings page.

Rhea-AI Summary

Uxin Ltd CEO Kun Dai reported that Xin Gao Group Limited purchased 3,606 American depositary shares on November 13, 2026, at $0.8001 per ADS. The purchase was reported under a Rule 10b5-1 trading plan. The reported position through Xin Gao Group Limited after the transaction was 197,440 ADS.

Rhea-AI Summary

Uxin Ltd CEO Kun Dai reported indirect purchases by Xin Gao Group Limited: 11,142 American depositary shares on November 10, 2026, at $0.8200 per share, and 5,445 American depositary shares on November 11, 2026, at $0.8273 per share. Both purchases were made under a Rule 10b5-1 plan.

Rhea-AI Summary

Uxin Ltd (UXIN) CEO Kun Dai reported an indirect purchase of 8,245 American depositary shares by Xin Gao Group Limited on November 6, 2026, at 0.7656 per ADS. The purchase was made under a Rule 10b5-1 plan; reported holdings after the transaction were 177,247 American depositary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported that Xin Gao Group Limited purchased 8,307 American depositary shares on November 5, 2026, at $0.8687 per American depositary share under a Rule 10b5-1 plan. The reported post-transaction position held indirectly through Xin Gao Group Limited was 169,002 American depositary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) Chief Executive Officer Kun Dai reported two purchases attributed to Xin Gao Group Limited: 6,100 American depositary shares at $0.8943 per ADS on November 3, 2026, and 5,115 ADS at $0.9535 per ADS on November 4, 2026. Both purchases were reported under a Rule 10b5-1 trading plan. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd CEO Dai Kun reported an indirect purchase of 1,300 American depositary shares by Xin Gao Group Limited on November 2, 2026, at $0.9307 per share. The purchase was made under a Rule 10b5-1 trading plan. The reported position following the transaction was 149,480 American depositary shares. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported an indirect purchase by Xin Gao Group Limited of 4,800 American depositary shares (ADS) at $0.9131 per ADS on October 30, 2026. The purchase was made under a Rule 10b5-1 plan. The reported resulting position was 148,180 ADS held indirectly through Xin Gao Group Limited. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer and director Kun Dai reported an indirect purchase by Xin Gao Group Limited of 7,732 American depositary shares on October 29, 2026, at $0.9696 per share. The purchase was made under a Rule 10b5-1 plan. The reported position held through Xin Gao Group Limited after the purchase was 143,380 American depositary shares. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd CEO and director Kun Dai reported a purchase of 3,500 American depositary shares (ADS) held indirectly through Xin Gao Group Limited, at $0.9714 per ADS on October 28, 2026. The purchase was made under a Rule 10b5-1 plan. Reported indirect holdings after the transaction were 135,648 ADS.

Rhea-AI Summary

Uxin Ltd (UXIN) reported that Xin Gao Group Limited purchased 5,800 American depositary shares on October 27, 2026, at $0.9044 per share. The purchase was reported under a Rule 10b5-1 plan. The reported position after the transaction was 132,148 American depositary shares, held indirectly by Chief Executive Officer and director Kun Dai. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer and director Kun Dai reported that Xin Gao Group Limited purchased 3,117 American depositary shares on October 26, 2026, at $0.8767 per share. The reported post-transaction holding was 126,348 American depositary shares, held indirectly by Xin Gao Group Limited. The purchase was made under a Rule 10b5-1 plan.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported that Xin Gao Group Limited indirectly purchased 6,000 American depositary shares on October 23, 2026, at 0.8472 per share under a Rule 10b5-1 plan. The reported resulting indirect position was 123,231 American depositary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) reported an indirect purchase by Xin Gao Group Limited of 7,000 American depositary shares on October 22, 2026, at $0.8901 per share; the reporting person was CEO and director Kun Dai. The purchase was made under a Rule 10b5-1 trading plan. The reported post-transaction position held by Xin Gao Group Limited was 117,231 American depositary shares.

Rhea-AI Summary

Uxin Ltd CEO Kun Dai reported that Xin Gao Group Limited purchased 4,002 American depositary shares on October 21, 2026, at $0.9384 per ADS. The reported indirect position held through Xin Gao Group Limited after the purchase was 110,231 ADS. The purchase was made under a Rule 10b5-1 plan. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) Chief Executive Officer Kun Dai reported an indirect purchase through Xin Gao Group Limited of 5,541 American depositary shares on October 20, 2026, at $0.9492 per share, under a Rule 10b5-1 trading plan. Reported holdings following the transaction were 106,229 American depositary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) reported that Xin Gao Group Limited purchased 6,211 American depositary shares on October 19, 2026, at $0.9798 per ADS under a Rule 10b5-1 plan. The purchase was reported by Kun Dai, Chief Executive Officer; the post-transaction position was 100,688 ADS held indirectly by Xin Gao Group Limited. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported an indirect purchase by Xin Gao Group Limited of 2,548 American depositary shares on October 16, 2026, at $1.0266 per share. The purchase was made under a Rule 10b5-1 plan. Xin Gao Group Limited's reported position following the transaction was 94,477 American depositary shares. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported an indirect purchase of 4,100 American depositary shares on October 15, 2026, through Xin Gao Group Limited. The reported price was $1.0421 per share, and the purchase was made under a Rule 10b5-1 plan. Reported indirect holdings after the transaction were 91,929 American depositary shares. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported an indirect purchase of 5,400 American depositary shares through Xin Gao Group Limited on October 14, 2026, at $1.0948 per share. The purchase was made under a Rule 10b5-1 plan. The reported position held through Xin Gao Group Limited after the transaction was 87,829 American depositary shares. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd director Li Ying received an award of 21,133 restricted share units on October 9, 2026, representing 21,133 American depositary shares. The units vested on the same date under the issuer’s share incentive plan. Her reported direct holdings afterward were 60,636 American depositary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) CEO Kun Dai reported two purchases of American depositary shares held indirectly through Xin Gao Group Limited: 9,027 ADSs on October 9, 2026, at $1.1278 each and 9,800 ADSs on October 12, 2026, at $1.1495 each. The purchases were made under a Rule 10b5-1 plan. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer and director Kun Dai reported an indirect purchase of 11,836 American depositary shares on October 8, 2026, at $1.1265 per share. The shares were held by Xin Gao Group Limited, and the purchase was reported under a Rule 10b5-1 plan. Reported holdings after the purchase were 63,602 American depositary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) CEO and director Kun Dai reported an indirect purchase of 5,505 American depositary shares by Xin Gao Group Limited on October 7, 2026, at $1.2128 per share. The reported position after the transaction was 51,766 American depositary shares. The purchase was reported under a Rule 10b5-1 trading plan. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) CEO and director Kun Dai reported an indirect purchase through Xin Gao Group Limited of 7,023 American depositary shares on October 6, 2026, at $1.2383 per share. The purchase was made under a Rule 10b5-1 trading plan. After the transaction, the reported indirect position was 46,261 American depositary shares. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer and director Kun Dai reported that Xin Gao Group Limited purchased 8,683 American depositary shares on October 5, 2026, at $1.2687 per share under a Rule 10b5-1 plan. The shares were held indirectly by Xin Gao Group Limited, whose reported position after the transaction was 39,238 American depositary shares. Each American depositary share represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd CEO and director Kun Dai reported an indirect purchase of 5,672 American depositary shares by Xin Gao Group Limited on October 2, 2026, at $1.2911 per ADS. The purchase was made under a Rule 10b5-1 trading plan; Xin Gao Group Limited’s reported holdings following the transaction were 30,555 ADS. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd Chief Executive Officer Kun Dai reported an indirect purchase by Xin Gao Group Limited of 9,000 American depositary shares at $1.4215 per share on October 1, 2026, under a Rule 10b5-1 plan. The reported position following the purchase was 24,883 American depositary shares.

Rhea-AI Summary

Uxin Ltd (UXIN) Chief Executive Officer Kun Dai reported that Xin Gao Group Limited purchased 7,443 American depositary shares on September 30, 2026, at $1.3362 per share. Xin Gao Group Limited held 15,883 American depositary shares after the transaction, which was made under a Rule 10b5-1 plan.

Rhea-AI Summary

Uxin Ltd (UXIN) Chief Executive Officer and director Kun Dai reported an indirect purchase of 8,440 American depositary shares through Xin Gao Group Limited on September 29, 2026, at 1.2572 per ADS under a Rule 10b5-1 trading plan. The reported post-transaction position was 8,440 ADS.

Rhea-AI Summary

Uxin Ltd director Li Bin (William) reported a purchase of 104,931,794 Class A ordinary shares on September 23, 2026, by Abundant Grace Investment Limited, at $0.0095 per share. The purchase is described as an open-market or private transaction. Li Bin indirectly controls NBNW, which held 71.5% of Abundant Grace. The transaction entry lists 13,115,578,738 shares following the purchase; a related ownership note separately states that Abundant Grace holds 18,317,745,804 shares. Separate indirect holdings are listed for FAME DRAGON GLOBAL LIMITED (17,030,073 shares) and Abundant Glory Investment L.P. (216,138,329 shares). No Rule 10b5-1 plan is reported.

Rhea-AI Summary

Ying Li reported acquisition or exercise transactions in this Form 4 filing.

Ying Li, a director of Uxin Ltd, received an equity compensation grant of 14,943 American depositary shares (ADS) on July 29, 2026. The award was issued as vested restricted share units under Uxin's share incentive plan at 0.0000 per ADS, increasing Li's direct holdings to 39,503 ADS. Each ADS represents 300 Class A ordinary shares.

Rhea-AI Summary

Uxin Ltd director-linked entities report internal share restructuring. On May 14, 2026, Abundant Grace Investment Limited distributed 558,725,100 Class A ordinary shares of Uxin Limited to Joy Capital III, L.P. for nil consideration, and 349,203,000 Class A ordinary shares to Brightest for nil consideration.

The filing explains that Astral Success Limited, BRIGHTEST SKY LIMITED and Joy Capital III, L.P. together hold large blocks of Uxin Class A ordinary shares and are ultimately controlled by Liu Erhai. He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest in them. The transactions are coded as “other” and reflect restructuring rather than market purchases or sales.

Rhea-AI Summary

Ying Li reported acquisition or exercise transactions in this Form 4 filing.

Uxin Ltd director Ying Li received a compensation grant of 7,454 American Depositary Shares (ADS) through restricted share units that vested immediately at no cash cost. After this award, Ying Li directly holds 24,560 ADS. Each ADS represents 300 Class A ordinary shares of Uxin Ltd.